$SEM

Scully Thomas sold (to issuer) $1.7M of SEM

Scully Thomas sold (to issuer) 103,424 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($1.71M total) on 2026-06-30.

Original reporting
SEC EDGAR · Scully Thomas
Published Jul 1, 2026, 6:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The newest fact is the specific insider sale size ($1.71M) and price ($16.50) on 2026-06-30, with holdings reduced to 0 shares.

02

Market read

This provides a fresh, primary-source datapoint on insider behavior, but it is not tied to earnings, guidance, or a fundamental corporate event.

03

What to watch

The filing does not state a 10b5-1 plan and the director ends with zero shares; traders may still monitor for follow-on insider activity or correlate with any concurrent corporate actions.

Relevance 6/10Novelty 5/10Timing: filed after-hours/late day (2026-07-01 14:27:42 ET)

Background

The article is an SEC Form 4 insider transaction disclosure for Select Medical Holdings Corp (SEM).

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings director Scully Thomas sold 103,424 shares to the issuer at $16.50 on 2026-06-30, leaving 0 shares.

Expected impact

Low likelihood of a sustained price move; any reaction should be muted unless part of a broader insider trend.

Evidence & confidence

Form 4 is primary-source, but the filing indicates sale to issuer and the director ends with 0 shares; without additional context (e.g., earnings, guidance, investigation), the incremental trading signal is modest.

Market effects

No direct sector read-across; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Because the transaction is coded as a sale to the issuer, it may reflect mechanical buyback participation rather than a bearish view on Select Medical’s outlook.

Key entities

  • Select Medical Holdings Corp

    Subject of the Form 4 insider transaction disclosure.

  • Scully Thomas

    Director who sold shares to the issuer under Form 4.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.